Cargando…
Asparaginase: an old drug with new questions
The long-term outcome of acute lymphoblastic leukemia has improved dramatically due to the development of more effective treatment strategies. L-asparaginase (ASNase) is one of the main drugs used and causes death of leukemic cells by systematically depleting the non-essential amino acid asparagine....
Autores principales: | Cecconello, Daiane Keller, Magalhães, Mariana Rodrigues de, Werlang, Isabel Cristina Ribas, Lee, Maria Lucia de Martino, Michalowski, Mariana Bohns, Daudt, Liane Esteves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417439/ https://www.ncbi.nlm.nih.gov/pubmed/31801703 http://dx.doi.org/10.1016/j.htct.2019.07.010 |
Ejemplares similares
-
Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center
por: Cecconello, Daiane Keller, et al.
Publicado: (2020) -
Follow our path with asparaginase activity: one technique, but different uses in clinical practice
por: Cecconello, Daiane Keller, et al.
Publicado: (2022) -
Allergic reactions to asparaginase: retrospective cohort study in pediatric patients with acute lymphoid leukemia
por: Battistel, Ana Paula, et al.
Publicado: (2021) -
From H1N1 to COVID-19: What we have seen in children with hemoglobinopathies
por: Oliveira, Claudia de Melo, et al.
Publicado: (2022) -
Influence of minimal residual disease by multiparametric flow cytometry at day 15 of induction in risk stratification of children with B-cell acute lymphoblastic leukemia treated at a referral hospital in southern Brazil
por: Silva, Klerize Anecely de Souza, et al.
Publicado: (2020)